Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Pomalidomide-13C5

Pomalidomide-13C5 (CC-4047-13C5) is 13C labeled Pomalidomide. Pomalidomide, the third-generation immunomodulatory agent, acts as molecular glue. Pomalidomide interacts with the E3 ligase cereblon and induces degradation of essential Ikaros transcription factors.

Product Specifications

CAS Number

[1416575-79-5]

Product Name Alternative

CC-4047-13C5

UNSPSC

12352005

Target

Apoptosis; Isotope-Labeled Compounds; Ligands for E3 Ligase; Molecular Glues

Related Pathways

Apoptosis; Others; PROTAC

Applications

Cancer-programmed cell death

Field of Research

Cancer

Smiles

O=C1N([13CH]2[13C](N[13C]([13CH2][13CH2]2)=O)=O)C(C3=C(N)C=CC=C31)=O

Molecular Formula

C8 13C5H11N3O4

Molecular Weight

278.21

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Lu J, et al. Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. Chem Biol. 2015 Jun 18;22 (6) :755-63.|[3]Liu D, et al. Tumour necrosis factor-α inhibits hepatic lipid deposition through GSK-3β/β-catenin signaling in juvenile turbot (Scophthalmus maximus L.) . Gen Comp Endocrinol. 2016 Mar 1;228:1-8.|[4]Li Z, et al. Pomalidomide shows significant therapeutic activity against CNS lymphoma with a major impact on the tumor microenvironment in murine models. PLoS One. 2013 Aug 5;8 (8) :e71754.|[5]Schafer PH, et al. Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs. J Pharmacol Exp Ther. 2003 Jun;305 (3) :1222-32.|[6]Hernandez-Ilizaliturri FJ1, et al. Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model. Clin Cancer Res. 2005 Aug 15;11 (16) :5984-92.|[7]Zhu YX, et al. Molecular mechanism of action of the immune-modulatory drugs, thalidomide, lenalidomide and pomalidomide in multiple myeloma. Leuk Lymphoma. 2013 Apr;54 (4) :683-7.

Shipping Conditions

Room temperature

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-10984S4/

Scientific Category

Isotope-Labeled Compounds

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Cy3-Linked Monoclonal Antibody to Interleukin 10 (IL10)
MBS2036259-01 0.1 mL

Cy3-Linked Monoclonal Antibody to Interleukin 10 (IL10)

Ask
View Details
Cy3-Linked Monoclonal Antibody to Interleukin 10 (IL10)
MBS2036259-02 0.2 mL

Cy3-Linked Monoclonal Antibody to Interleukin 10 (IL10)

Ask
View Details
Cy3-Linked Monoclonal Antibody to Interleukin 10 (IL10)
MBS2036259-03 0.5 mL

Cy3-Linked Monoclonal Antibody to Interleukin 10 (IL10)

Ask
View Details
Cy3-Linked Monoclonal Antibody to Interleukin 10 (IL10)
MBS2036259-04 1 mL

Cy3-Linked Monoclonal Antibody to Interleukin 10 (IL10)

Ask
View Details
Cy3-Linked Monoclonal Antibody to Interleukin 10 (IL10)
MBS2036259-05 5 mL

Cy3-Linked Monoclonal Antibody to Interleukin 10 (IL10)

Ask
View Details
Cy3-Linked Monoclonal Antibody to Interleukin 10 (IL10)
MBS2036259-06 5x 5 mL

Cy3-Linked Monoclonal Antibody to Interleukin 10 (IL10)

Ask
View Details